BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8158309)

  • 1. Evaluating sympathetic activity in human hypertension.
    Mancia G; Grassi G; Parati G; Daffonchio A
    J Hypertens Suppl; 1993 Dec; 11(5):S13-9. PubMed ID: 8158309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
    Jennings GL
    J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic tools for assessment of adrenergic nerve activity in human hypertension.
    Ibsen H; Julius S
    Fed Proc; 1984 Jan; 43(1):67-71. PubMed ID: 6317465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.
    Moretti JL; Burke SL; Evans RG; Lambert GW; Head GA
    J Hypertens; 2009 Sep; 27(9):1838-48. PubMed ID: 19512943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system in human hypertension.
    Mancia G; Grassi G; Parati G; Zanchetti A
    Acta Physiol Scand Suppl; 1997; 640():117-21. PubMed ID: 9401621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique.
    Grassi G; Bolla GB; Seravalle G; Quarti-Trevano F; Facchetti R; Mancia G
    J Hypertens; 2008 Nov; 26(11):2185-90. PubMed ID: 18854759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased regional sympathetic nervous activity in human hypertension: causes and consequences.
    Esler M; Lambert G; Jennings G
    J Hypertens Suppl; 1990 Dec; 8(7):S53-7. PubMed ID: 1965656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic activity, blood pressure variability and end organ damage in hypertension.
    Mancia G; Di Rienzo M; Parati G; Grassi G
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S3-8. PubMed ID: 9321734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in the regulation of sympathetic activity in human hypertension.
    de Champlain J; Cléroux J; Lebeau R; Gonzalez M; Nadeau R
    Clin Invest Med; 1987 Nov; 10(6):573-80. PubMed ID: 3326696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why study sympathetic nervous system?
    Sinski M; Lewandowski J; Abramczyk P; Narkiewicz K; Gaciong Z
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():79-92. PubMed ID: 17244940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic cardiac influence and arterial blood pressure instability.
    Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X
    Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods to quantify sympathetic cardiovascular influences.
    Mancia G; Daffonchio A; Di Rienzo M; Ferrari AU; Grassi G
    Eur Heart J; 1998 Jun; 19 Suppl F():F7-13. PubMed ID: 9651729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation.
    Rundqvist B; Elam M; Eisenhofer G; Friberg P
    J Heart Lung Transplant; 1996 May; 15(5):516-26. PubMed ID: 8771507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
    Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
    Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
    Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
    Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.